Pro Re Nata Intravitreal Bevacizumab for the Treatment of Idiopathic Choroidal Neovascular Membrane.

about

Pro Re Nata Intravitreal Bevacizumab for the Treatment of Idiopathic Choroidal Neovascular Membrane.

Item

http://www.wikidata.org/entity/Q51101818

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Pro Re Nata Intravitreal Bevac ...... horoidal Neovascular Membrane.

@en

Pro Re Nata Intravitreal Bevac ...... horoidal Neovascular Membrane.

@nl

type

Item

label

Pro Re Nata Intravitreal Bevac ...... horoidal Neovascular Membrane.

@en

Pro Re Nata Intravitreal Bevac ...... horoidal Neovascular Membrane.

@nl

prefLabel

Pro Re Nata Intravitreal Bevac ...... horoidal Neovascular Membrane.

@en

Pro Re Nata Intravitreal Bevac ...... horoidal Neovascular Membrane.

@nl

P1476

Pro Re Nata Intravitreal Bevac ...... Choroidal Neovascular Membrane

@en

P2093

Aneesha Lobo

http://www.w3.org/2001/XMLSchema#string

Anindya Kishore Majumdar

http://www.w3.org/2001/XMLSchema#string

P2860

The prognosis of idiopathic choroidal neovascularization in persons younger than 50 years of age.

Ranibizumab for choroidal neovascularization secondary to causes other than age-related macular degeneration: a phase I clinical trial.

Photodynamic treatment versus photodynamic treatment associated with systemic steroids for idiopathic choroidal neovascularisation

Idiopathic choroidal neovascularisation as the inaugural sign of multiple evanescent white dot syndrome.

Idiopathic subfoveal choroidal neovascular membrane in a 21-month-old child: ultrastructural features and implication for membranogenesis.

Results of 1-year follow-up examinations after intravitreal bevacizumab administration for idiopathic choroidal neovascularization.

Treatment of idiopathic subfoveal choroidal neovascular lesions using photodynamic therapy with verteporfin.

Photodynamic therapy with verteporfin for subfoveal idiopathic choroidal neovascularization: one-year results from a prospective case series.

Severe pigment epithelial alterations in the treatment area following photodynamic therapy for classic choroidal neovascularization in young females.

Intravitreal bevacizumab for subfoveal idiopathic choroidal neovascularization.

P304

463-466

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/08820538.2014.962172

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rupak Roy

Kumar Saurabh

Pradeep Kumar Panigrahi

P577

2014-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25392193

http://www.w3.org/2001/XMLSchema#string

P921

bevacizumab